Acadia Healthcare to acquire Partnerships in Care for $660M Acadia Healthcare Business, Inc. today announced the signing of a definitive contract to acquire Partnerships in Treatment for about $660 million in cash. PiC may be the second largest independent provider of inpatient behavioral healthcare services in britain, working 23 inpatient psychiatric facilities with over 1,200 beds zithromax azithromycin 250 mg . For 2013, PiC produced revenue of approximately $285 million and altered EBITDA of around $75 million. Acadia offers received a committed action from Bank of America Merrill Lynch concerning financing of the purchase.
This brand-new partnership with Access Pharmaceuticals Inc. Represents an excellent opportunity to make sure that cancer patients affected by oral mucositis can gain access to MuGard, to greatly help manage this condition that there are limited effective treatment options, said Peter Stein, CEO of Norgine. He continued, This collaboration is usually further evidence of Norgine's commitment to acquire specialty pharmaceutical items to strengthen its portfolio. ? Â Â.. Gain access to Pharmaceuticals enters into special license agreement with Norgine ACCESS PHARMACEUTICALS, INC. , an emerging biopharmaceutical firm, today announced that it had entered into a special license contract with Norgine B.V., a leading independent European specialty pharmaceutical firm, for the commercialization of MuGard in Europe.